Obesity

A retrospective study presented at the 2025 American Society for Metabolic and Bariatric Surgery Annual Meeting in Washington, D.C examines the role of gastroesophageal reflux disease, sex, and insurance...

Recent studies show distinct metabolic disruptions in children with multisystem inflammatory syndrome in children, plaque progression in adults post–COVID-19, and surprising pneumococcal risk patterns. ...

A randomized controlled trial presented at the 2025 American Society for Metabolic and Bariatric Surgery Annual Meeting in Washington, D.C, found that a structured continuity of care model can significantly...

A retrospective cohort study highlights the potential of GLP-1 receptor agonists to reduce BMI and support glycemic control in adolescents and young adults with type 1 diabetes and obesity without...

Patients undergoing robotic-assisted sleeve gastrectomy reported higher post-operative pain scores and required more intra-operative opioids compared to those receiving laparoscopic sleeve gastrectomy,...

A 3-port robotic sleeve gastrectomy technique demonstrated shorter operative times, reduced post-operative pain, and lower material costs compared with a traditional 4-port approach in patients with high...

A cross-sectional study identifies key predictors of peritonitis in ovarian cancer hospitalizations, highlighting early intervention opportunities.

A retrospective cohort study found that patients on GLP-1 agonists had a lower risk of periprosthetic joint infection but a higher risk of periprosthetic fractures following total knee arthroplasty.

At the American Association of Clinical Endocrinology 2025 Annual Meeting, Daniel Drucker, OC, MD, FRCPC, FRSC, FRS, discussed the evolving scope of GLP-1–based therapies, highlighting emerging molecules,...

A post hoc analysis of the SURMOUNT-1 trial reveals that cardiometabolic improvements achieved after 176 weeks of tirzepatide may diminish significantly within 17 weeks of treatment cessation, particularly...